Strategies For Investigation And Control Of Process- And Degradation-Related Impurities

Separation Science and Technology

Volumn 5, Issue C, 2004, Pages 89-117

  Olsen, Bernard A ^a   Baertschi, Steven W ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79955692073     PISSN: 18771718     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0149-6395(03)80007-7     Document Type: Book

References (43)

1. International Conference on Harmonisation, Impurities in New Drug Substances, Q3A, January 1996
2. International Conference on Harmonisation, Impurities in New Drug Substances, Draft, Q3A(R), February 2002
3. International Conference on Harmonisation, Impurities in New Drug Products, Q3B, November 1996
4. International Conference on Harmonisation, Impurities in New Drug Products, Draft, Q3B(R), October 1999
5. Identification and Determination of Impurities in Drugs, Gorog, S. (Ed.), Elsevier, Amsterdam, 2000.
6. Niessen, W. M. A. Chimia 53:478-483, 1999.
7. Hilhorst, M. J., Somsen, G. W. and de Jong, G. J. Electrophoresis 22:2542-2564, 2001.
8. Hilhorst, M. J., Derksen, A. P., Steringa, M., Somsen, G. W. and de Jong, G. J. Electrophoresis 22:1337-1344, 2001.
9. Ermer, J. and Vogel, M. Biomedical Chromatography 16:373-383, 2000.
10. Gorog, S. Current Trends in Analytical Chemistry 1:11-18, 1998.
11. International Conference on Harmonisation, Specifications: Test Procedures and Acceptance Criterial for New Drug Substances and New Drug Products: Chemical Substances, Q6A, October 1999
12. International Conference on Harmonisation, Impurities: Residual Solvents, Q3C, July 1997
13. Góróg, S., Babják, M., Balogh, G., Brlik, J., Csehi, A., Dravecz, P., Gazdag, M., Horváth, P., Laukó, A. and Varga, K. Talanta 44:1517-1526, 1997.
14. Giron, D. Boll Chim. Farmaceutico 133:201-220, 1994.
15. Wirth, D. D., Miller, M. S., Boini, S. K. and Koenig, T.M. Org. Proc. Res. Dev. 4:513-519, 2000.
16. Wirth, D. D., Olsen, B. A., Hallenbeck, D. K., Lake, M. E., Gregg, S. M. and Perry, P.M. Chromatographia 46:511-523, 1997.
17. Pharmacopeial Forum, 26:193, 2000
18. Markey, S. P. and Schmuff, N. R. Med. Res. Rev. 4:389-429, 1986.
19. International Conference on Harmonisation, Stability Testing of New Drug Substances and Products, QIA, September 1994
20. International Conference on Harmonisation, Stability Testing: Photostability Testing of New Drug Substances and Products, QIB, November 1996
21. Thatcher, S. R., Mansfield, R. K., Miller, R. B., Davis, C. W. and Baertschi, S. W. Pharmaceutical Technology, March 98-110, 2001.
22. Thatcher, S. R., Mansfield, R. K., Miller, R. B., Davis, C. W. and Baertschi, S. W. Pharmaceutical Technology, April 50-62, 2001.
23. Boccardi, G., Deleuze, C, Gachon, M., Palmisano, G., and Vergnaud, J. P. J. Pharm Sci. 81:2, 183, 1992.
24. Boccardi, G. Il Farmaco. 49:6, 431, 1994.
25. Hovorka, S. W. and Schoneich, C. J. Pharm. Sci. 90(3):253-269, 2001.
26. Johnson, D. M. and Gu, L. C. Autoxidation and antioxidants, In Encyclopedia of Pharmaceutical Technology (Swarbrick, J. and Boylan, J.C. Eds.) Vol. I, Marcel Dekker, Inc., New York, pp. 415-449, 1998.
27. Waterman, K. C, Adami, R. C, Alsante, K. M., Hong, J., Landis, M. S., Lombardo, F. and Roberts, C. J. Pharmaceutical Development and Technology 7:1, 1-32, 2002.
28. Unpublished results, Karen Alsante, Pfizer
29. March, J. Advanced Organic Chemistry: Reactions, Mechanisms, and Structure, 3rd ed. John Wiley & Sons, New York, p. 1088, 1985.
30. Ginsburg, E. J., Stephens, D. A., West, P. R., Buko, A. M., Robinson, D. H., Li, L. C. and Bommiredi, A. R. J. Pharm. Sci. 89:6, 766-770, 2000.
31. McGinity, J. W., Hill, J. A. and La Via, A. L. J. Pharm. Sci. 64:2, 356-357, 1975.
32. Chafetz, L., Hong, W.-H., Tsilifonis, D. C, Taylor, A. K. and PhiHp, J. J. Pharm. Sci. 73:8, 1186-1187, 1984.
33. Hartauer, K., Arbuthnot, G., Baertschi, S. W., Johnson, R., Luke, W., Pearson, N., Rickard, E., Tsang, P. and Wiens, R. Pharmaceutical Development and Technology 5:3, 303-319, 2000.
34. International Conference on Harmonisation, Stability Testing of New Drug Substances and Products, QIA, September 1994
35. McNabb, T. J., Cremesti, A. E., Brown, P. R. and Fischl, A. A. Seminars in Food Analysis, 4:53-70, 1999.
36. Snyder, L. R., Kirkland, J. J. and Glajch, J. L. Practical HPLC Method Development, 2nd ed. John Wiley & Sons, NY, pp. 80-81, 1997.
37. Nussbaum, M.A., Baertschi, S.W. and Jansen, P.J. J. Pharm. Biomed. Anal, 27:983-993, 2002.
38. Korner, A., LCIGC, 20(4):364-373, 2002.
39. Qin, X.-Z, Ip, D. P., Chang, K. H.-C, Dradransky, P. M., Brooks, M. A. and Sakuma, T. J. Pharm. Biomed. Anal. 12(2): 2212-2233, 1994.
40. Wirth, D. D., Baertschi, S. W., Johnson, R. A., Maple, S. R., Miller, M. S., Hallenbeck, D. K. and Gregg, S. M. (1998). J. Pharm. Sci. 87(1): 31-39, 1998.
41. Schildcrout, S. A., Risley, D. S. and Kleeman, R. L. Drug Development and Industrial Pharmacy 19(10):1113-1130, 1993.
42. Serajuddin, A. T. M., Thakur, A. B., Ghoshal, R. N., Fakes, M. G., Ranadive, S. A., Morris, K. R. and Varia, S. A. J. Pharm. Sci. 88(7):696-704, 1999.
43. Jansen, P. J., Oren, P. L., Kemp, C. A., Maple, S. R. and Baertschi, S. W. J. Pharm. Sci. 87(l):81-85, 1998.